A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer.
about
Specific Macronutrients Exert Unique Influences on the Adipose-Liver Axis to Promote Hepatic Steatosis in Mice.Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models.Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances.Overactivation of intestinal Sterol Response Element Binding Protein 2 promotes diet-induced non-alcoholic steatohepatitis.Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease.Mid-infrared fibre evanescent wave spectroscopy of serum allows fingerprinting of the hepatic metabolic status in mice.Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.Activation of pluripotent genes in hepatic progenitor cells in the transition of nonalcoholic steatohepatitis to pre-malignant lesions.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis.In NAFLD, You Are What You Eat, Not Simply How Much You EatInflammation, mitochondrial metabolism and nutrition: the multi-faceted progression of non-alcoholic fatty liver disease to hepatocellular carcinomaNon-alcoholic fatty liver disease (NAFLD) models in drug discovery.The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease.Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease.Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.Lychee pulp phenolics ameliorate hepatic lipid accumulation by reducing miR-33 and miR-122 expression in mice fed a high-fat diet.Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis.Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis.Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.A Simple Diet- and Chemical-Induced Murine NASH Model with Rapid Progression of Steatohepatitis, Fibrosis and Liver Cancer.Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs.Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.Gynostemma pentaphyllum Attenuates the Progression of Nonalcoholic Fatty Liver Disease in Mice: A Biomedical Investigation Integrated with In Silico Assay.Hepatic lesions induced by feeding Western diets to Zucker fatty rats, an insulin-resistant model
P2860
Q33802995-759229E7-E69F-498F-85C1-06C8D7050874Q37166770-6416E541-FBA6-4265-BD3A-2B8104FDC212Q37561108-DE87F0AE-851A-4201-950F-04AD701B2130Q38642491-3D3598D6-4371-4B5E-8F77-0E34143A775FQ38737633-1F7F00F9-FD6A-4DC9-AAC3-AD3CE3603E66Q39322184-028C30CF-2682-4C5D-B0E8-B8BA754F70E8Q39445103-B4B9E61A-D310-4857-8808-8EB562EC9F37Q40059071-EC659881-515E-4A56-80A8-41329565452FQ41921861-5B39A6B4-28C8-4377-A52A-A331B2A6FBB8Q41969545-C929D8EC-A4EF-4F8F-A370-3FE433023C19Q42346715-4BB14DD0-526D-43CF-850F-897955FB4651Q42380811-6710AA23-E794-4BA6-8491-649D07FBDFF4Q46251147-74714234-198A-4E92-A8AB-D7D80936A0AAQ46606052-666BE47D-888A-4677-B7AC-0C74AE7D8FEFQ47154314-B652B1D7-CAD5-47A3-9BC1-6273676A3432Q48242025-B937BDD6-D946-4486-9C78-083D67B0B94AQ48313374-05735F35-8D06-4D26-BDA1-2FD419E8E8B0Q49331156-9AA01914-86F2-4DC1-86B1-9879095B0D99Q49394966-ADE91A50-ABB5-47DF-AAB6-38BF0A690CA6Q50142613-0E721EBC-7911-4513-A168-2BDFFAB59658Q50147806-30220014-EEF3-471E-A593-D5B860D14518Q52582202-45B2A072-01C1-4C89-A485-B9455AF923E4Q52639618-3C27AC62-1FDC-465C-964B-500C388C16B5Q54943797-80AB8313-2036-405C-BB6C-FF4B3AAB6BB1Q55078604-7D148FBF-18C3-41F0-A2B0-C1F69B0723E3Q55387475-76EE4FCC-B054-4BEC-AFAB-3E4BA0F26192Q58596261-1A244D2E-9734-404E-8738-3E8C03D311B0
P2860
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A diet-induced animal model of ...... ase and hepatocellular cancer.
@en
type
label
A diet-induced animal model of ...... ase and hepatocellular cancer.
@en
prefLabel
A diet-induced animal model of ...... ase and hepatocellular cancer.
@en
P2093
P2860
P1476
A diet-induced animal model of ...... ase and hepatocellular cancer.
@en
P2093
Amon Asgharpour
Arun J Sanyal
Bubu A Banini
Daniel Contaifer
Dayanjan S Wijesinghe
Divya Prasanna Kumar
Faridoddin Mirshahi
Hae-Ki Min
Kalyani Daita
Mulugeta Seneshaw
P2860
P304
P356
10.1016/J.JHEP.2016.05.005
P577
2016-05-13T00:00:00Z